The Fly | VVOS

Proprietary Airway Remodeling Technology: The Vivos System is a patented and proprietary non-invasive treatment that aims to remodel the upper airway and address the underlying anatomical causes of obstructive sleep apnea (OSA), rather than merely managing symptoms.

Addressing Root Cause of OSA: Unlike traditional methods such as CPAP or other oral appliances that provide symptomatic relief, Vivos focuses on structural changes that can lead to a more permanent or significant resolution of OSA for patients.

Significant Underserved Market Opportunity: Obstructive Sleep Apnea affects millions of people globally, with a large percentage remaining undiagnosed or inadequately treated, presenting a vast market potential for Vivos' solution.

Limited Market Adoption: The successful adoption of their oral appliance by dentists and patients for treating sleep apnea is critical for revenue growth.

Significant Competition: Vivos Therapeutics faces intense competition from established CPAP therapy, other oral appliances, and surgical solutions for sleep apnea.

Financial Health and Funding Needs: As a growth company, Vivos Therapeutics may require additional capital to fund its operations, sales expansion, and research, potentially leading to dilution.

Limited Market Adoption: The successful adoption of their oral appliance by dentists and patients for treating sleep apnea is critical for revenue growth.

Significant Competition: Vivos Therapeutics faces intense competition from established CPAP therapy, other oral appliances, and surgical solutions for sleep apnea.

Financial Health and Funding Needs: As a growth company, Vivos Therapeutics may require additional capital to fund its operations, sales expansion, and research, potentially leading to dilution.

Today

Vivos Therapeutics price target lowered by $1 at Alliance Global, here's why